The market’s been dragging. These five names haven’t. They’re not just climbing. They’re loading. And when they go, they won’t ask permission.
Hims & Hers Health (HIMS) is already up 138% year-to-date. It closed Friday at $64.22 and ticked up to $64.47 after hours. Volume hit 42.2 million, beating the 40.3 million average. The 52-week high is $72.98. That’s within reach. The company’s market cap is now $14.3 billion. Revenue growth is still running above 60%. Margins are expanding. If the current pace holds, $130 is not a moonshot. It’s a rerating.
Oscar Health (OSCR) jumped 13% Friday to $21.22 and added another 1% after hours to $21.43. That’s the highest close in over a year. The 52-week high is $23.79. Volume exploded to 70.6 million, more than five times the average. Market cap is now $5.4 billion. EPS is up 603% year-over-year. If the ACA market holds and Oscar keeps scaling, $40 is not a stretch. It’s overdue.
Advanced Micro Devices (AMD) closed at $128.24. Post-market dipped slightly to $128.17. The 52-week high is $187.28. That’s the old ceiling. The new one is AI. AMD’s MI350 chips are shipping this year. MI400s are coming next. Data center revenue jumped 57% in Q1. The Saudi-backed Humain deal is worth $10 billion. If AMD captures even 10% of the AI accelerator market by 2028, $250 is not a fantasy. It’s a base case.
Robinhood (HOOD) closed at $78.50. Post-market slipped to $78.35. The 52-week high is $79.38. That’s about to fall. The company just acquired Bitstamp and WonderFi. It’s expanding into Canada and building a full-stack wealth platform. Market cap is $69.3 billion. EPS is $1.34. If crypto stays hot and Robinhood keeps adding products, $120 is not a dream. It’s a rerating.
Lemonade (LMND) closed at $44.31. Post-market pushed it to $44.64. The 52-week high is $53.85. That’s next. The company just crossed $1 billion in in-force premiums. Revenue is up 27%. Gross loss ratio dropped from 88% to 73%. Market cap is $3.2 billion. If Q2 revenue hits $160 million and the loss ratio keeps falling, $100 is not a stretch. It’s a reversion to mean.
Sources:
https://longforecast.com/hims-stock
https://stockanalysis.com/stocks/oscr/forecast/
https://longforecast.com/hood-stock
https://invezz.com/news/2025/06/09/lemonade-stock-price-analysis-technicals-point-to-more-gains/
NOTE: This is not financial advice. Please conduct your own due diligence.